BL Pharmtech Corp.

KOSDAQ:A065170 주식 보고서

시가총액: ₩18.6b

BL Pharmtech 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hyo-Lim Lee

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Sep 03
BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

May 21
Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Mar 07
Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Mar 14
Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Jan 20
Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

Nov 28
Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

CEO

Hyo-Lim Lee

no data

테뉴어

Mr. Hyo-Lim Lee serves as the Chief Executive Officer of BL Pharmtech Corp. (formerly known as NRD Co., Ltd.).